Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma
Condition: NK/T Cell Lymphoma Nos Interventions: Drug: Sintilimab; Drug: Lenalidomide Sponsor: Beijing Tongren Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials